Treatment of refractory polymyalgia rheumatica with etanercept: An open pilot study

Wiley - Tập 57 Số 8 - Trang 1514-1519 - 2007
Maria Grazia Catanoso1, Pierluigi Macchioni1, Luigi Boiardi1, Nicolò Pipitone1, Carlo Salvarani1
1Arcispedale Santa Maria Nuova, Reggio Emilia, Italy

Tóm tắt

AbstractObjectiveTo investigate whether etanercept has a steroid‐sparing effect in the treatment of patients with relapsing polymyalgia rheumatica (PMR).MethodsThe study group comprised patients with relapsing PMR who were not able to reduce their prednisone dosage below 7.5–10 mg/day and who had experienced corticosteroid‐related side effects. Patients received injections of etanercept 25 mg twice weekly for 24 weeks, and were followed up for 3 additional months after treatment withdrawal. Patients regularly underwent clinical assessment, measurement of erythrocyte sedimentation rate and C‐reactive protein level, and ultrasound (US) examination of the shoulders during the 9 months of the followup period.ResultsAll 6 enrolled patients responded to etanercept with sustained remission (improvement of at least 70% according to European League Against Rheumatism response criteria for PMR in 4 patients and at least 50% in 2 patients) and were able to significantly reduce their median prednisone daily dosage without experiencing a disease relapse (8.75 mg versus 2.5 mg; P = 0.026) at the end of the 9‐month study period. US shoulder examination performed at the end of followup demonstrated a parallel reduction of glenohumeral and periarticular inflammation. A significant reduction in the cumulative prednisone dose 9 months before versus the 9‐month study period was observed (mean ± SD 1,767 ± 524 mg versus 730 ± 182 mg; P = 0.028). Three patients developed nonsevere side effects: bacterial cystitis in 2 and influenza in 1.ConclusionThese results, which should be confirmed in a controlled study, suggest that etanercept may be a safe and useful corticosteroid‐sparing agent in relapsing PMR.

Từ khóa


Tài liệu tham khảo

10.1056/NEJMra011913

Gonzalez‐Gay MA, 1999, Diagnostic approach in a patient presenting with polymyalgia, Clin Exp Rheumatol, 17, 276

10.1136/bmj.300.6721.344

10.1111/j.0954-6820.1986.tb02796.x

10.1002/1529-0131(199807)41:7<1221::AID-ART12>3.0.CO;2-W

Salvarani C, 1987, Polymyalgia rheumatica and giant cell arteritis: a 5‐year epidemiologic and clinical study in Reggio Emilia, Italy, Clin Exp Rheumatol, 5, 205

10.1002/art.1780401022

10.1136/ard.55.4.218

Ferraccioli G, 1996, Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study, J Rheumatol, 23, 624

Ferraccioli GF, 2000, Steroid sparing therapeutic approaches to polymyalgia rheumatica‐giant cell arteritis: state of the art and perspectives, Clin Exp Rheumatol, 18, S58

10.7326/0003-4819-141-7-200410050-00005

10.1002/art.20335

10.1016/S0140-6736(00)02530-7

10.1056/NEJM199707173370301

10.7326/0003-4819-130-6-199903160-00004

10.1056/NEJMoa012664

10.1002/art.11017

10.1002/art.11325

Salvarani C, 2003, Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study, J Rheumatol, 30, 760

Migliore A, 2005, TNF‐alpha blockade induce clinical remission in patients affected by polymyalgia rheumatica associated to diabetes mellitus and/or osteoporosis: a seven cases report, Eur Rev Med Pharmacol Sci, 9, 373

10.1002/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO;2-Y

10.1016/0049-0172(84)90012-X

10.1002/art.1780310302

Gonzalez‐Gay MA, 2000, The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain, J Rheumatol, 27, 2179

Ranza R, 1993, The Italian version of the Functional Disability Index of the Health Assessment Questionnaire: a reliable instrument for multicenter studies on rheumatoid arthritis, Clin Exp Rheumatol, 11, 123

10.1136/ard.2003.011379

10.1136/ard.2002.002618

Cantini F, 2001, Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case‐control study, J Rheumatol, 28, 1049

10.1002/art.20901

Kremers HM, 2005, Relapse in a population based cohort of patients with polymyalgia rheumatica, J Rheumatol, 32, 65

Gonzalez‐Gay MA, 1999, The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10‐year study, J Rheumatol, 26, 1326

10.1136/ard.2006.051979

10.7326/0003-4819-146-9-200705010-00005

Butler DM, 1995, Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures: comparison of monoclonal anti TNF‐alpha antibody with the interleukin‐1 receptor antagonist, Eur Cytokine Netw, 6, 225

Thông tin
Thông tin xuất bản

Wiley

Tập 57 Số 8

1514-1519

Thông tin tác giả